Brooke E. Schmeichel, Ph.D. - Publications

Affiliations: 
2012 Psychology University of Wisconsin, Madison, Madison, WI 

14 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2016 España RA, Schmeichel BE, Berridge CW. Norepinephrine at the Nexus of Arousal, Motivation and Relapse. Brain Research. PMID 26773688 DOI: 10.1016/j.brainres.2016.01.002  1
2015 Schmeichel BE, Barbier E, Misra KK, Contet C, Schlosburg JE, Grigoriadis D, Williams JP, Karlsson C, Pitcairn C, Heilig M, Koob GF, Vendruscolo LF. Hypocretin receptor 2 antagonism dose-dependently reduces escalated heroin self-administration in rats. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 40: 1123-9. PMID 25367502 DOI: 10.1038/npp.2014.293  1
2014 Schmeichel BE, Berridge CW. Amphetamine acts within the lateral hypothalamic area to elicit affectively neutral arousal and reinstate drug-seeking. The International Journal of Neuropsychopharmacology / Official Scientific Journal of the Collegium Internationale Neuropsychopharmacologicum (Cinp). 17: 63-75. PMID 23895988 DOI: 10.1017/S1461145713000734  1
2014 Koob GF, Buck CL, Cohen A, Edwards S, Park PE, Schlosburg JE, Schmeichel B, Vendruscolo LF, Wade CL, Whitfield TW, George O. Addiction as a stress surfeit disorder. Neuropharmacology. 76: 370-82. PMID 23747571 DOI: 10.1016/j.neuropharm.2013.05.024  1
2013 Kallupi M, Wee S, Edwards S, Whitfield TW, Oleata CS, Luu G, Schmeichel BE, Koob GF, Roberto M. Kappa opioid receptor-mediated dysregulation of gamma-aminobutyric acidergic transmission in the central amygdala in cocaine addiction. Biological Psychiatry. 74: 520-8. PMID 23751206 DOI: 10.1016/j.biopsych.2013.04.028  1
2013 Schmeichel BE, Berridge CW. Neurocircuitry underlying the preferential sensitivity of prefrontal catecholamines to low-dose psychostimulants. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 38: 1078-84. PMID 23303075 DOI: 10.1038/npp.2013.6  1
2013 Schmeichel BE, Berridge CW. Wake-promoting actions of noradrenergic α1 - and β-receptors within the lateral hypothalamic area. The European Journal of Neuroscience. 37: 891-900. PMID 23252935 DOI: 10.1111/ejn.12084  1
2013 Schmeichel BE, Zemlan FP, Berridge CW. A selective dopamine reuptake inhibitor improves prefrontal cortex-dependent cognitive function: potential relevance to attention deficit hyperactivity disorder. Neuropharmacology. 64: 321-8. PMID 22796428 DOI: 10.1016/j.neuropharm.2012.07.005  1
2013 Berridge CW, Devilbiss DM, Spencer RC, Schmeichel BE. Neural Mechanisms Underlying the Cognition-Enhancing Actions of Pyschostimulants: Relevance to ADHD Catecholamine Research in the 21st Century: Abstracts and Graphical Abstracts, 10th International Catecholamine Symposium, 2012. 168-169. DOI: 10.1016/B978-0-12-800044-1.00148-3  1
2012 Berridge CW, Schmeichel BE, España RA. Noradrenergic modulation of wakefulness/arousal. Sleep Medicine Reviews. 16: 187-97. PMID 22296742 DOI: 10.1016/j.smrv.2011.12.003  1
2012 Berridge CW, Devilbiss DM, Spencer RC, Schmeichel BE, Arnsten AFT. Attention deficit hyperactivity disorder Translational Neuroscience: Applications in Psychiatry, Neurology, and Neurodevelopmental Disorders. 303-320. DOI: 10.1017/CBO9780511980053.018  1
2008 Vittoz NM, Schmeichel B, Berridge CW. Hypocretin /orexin preferentially activates caudomedial ventral tegmental area dopamine neurons. The European Journal of Neuroscience. 28: 1629-40. PMID 18973582 DOI: 10.1111/j.1460-9568.2008.06453.x  1
2006 Berridge CW, Devilbiss DM, Andrzejewski ME, Arnsten AF, Kelley AE, Schmeichel B, Hamilton C, Spencer RC. Methylphenidate preferentially increases catecholamine neurotransmission within the prefrontal cortex at low doses that enhance cognitive function. Biological Psychiatry. 60: 1111-20. PMID 16806100 DOI: 10.1016/j.biopsych.2006.04.022  1
2005 Berridge CW, Stellick RL, Schmeichel BE. Wake-promoting actions of medial basal forebrain beta2 receptor stimulation. Behavioral Neuroscience. 119: 743-51. PMID 15998195 DOI: 10.1037/0735-7044.119.3.743  1
Show low-probability matches.